The global intravenous infusion pump market was valued at $4,154.30 million in 2020, and is estimated to reach $8,147.20 million by 2030, growing at a CAGR of 7.10% from 2021 to 2030.
Infusion pump is a medical device that delivers fluids such as nutrients and medications into a patient’s body in controlled amounts. Infusion pumps are increasingly used in clinical settings such as hospitals, nursing homes, and in home.
In general, an infusion pump is operated by a trained user who programs the rate and duration of fluid delivery through a built-in software interface. Infusion pumps offer significant advantages over manual administration of fluids, including the ability to deliver fluids in small volumes and the ability to deliver fluids at precisely programmed rates or automated intervals. Furthermore, infusion pumps can deliver nutrients or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers.
Chronic diseases are the major cause of disability and deaths across the globe, and 80% of deaths due to chronic diseases occur in low- and middle-income countries. In addition, chronic diseases include cardiovascular diseases, stroke, cancer, chronic respiratory diseases, and diabetes, wherein cardiovascular disease is the major cause of deaths globally, according to WHO. The prevalence of cancer has increased drastically, raising the global burden to 19.3 million cases in 2020, as stated by the NCBI. Such diseases have become a major public health concern and need a quick and regulated mode of treatment. Rise in incidence of diseases such as cardiovascular and cancer has led to an increase in demand for intravenous infusion pump devices.
The possibility of medication errors exists due to increase in disease burden. Thus, there is a need for advanced delivery systems that are more safe, efficient, and standardized. Furthermore, the introduction of smart intravenous infusion pumps or next-generation intravenous pumps is imparting lucrative growth opportunities for the market. Smart pumps are intelligent intravenous infusion devices that are embedded with a computer software system aimed at decreasing drug dosing errors through the presence of drug libraries ensuring safe medication administration.
The applications of these intravenous pumps in intermittent therapy for delivery of antibiotics or continuous infusion therapy for the delivery of chemotherapeutic medications are prominent. According to NCBI, the use of ambulatory pumps is common and will continue to grow annually. Factors such as surge in geriatric population, rise in prevalence of chronic diseases, and low cost are likely to propel the market. Moreover, rise in the number of individuals undergoing surgeries globally for cosmetic, cancer, cardiovascular, or other ailments is likely to have a positive impact on the market growth.
Infusion pumps and ventilators can be considered critical devices, as these devices are used in ICUs, CCUs, and emergency departments. IV infusion is a common need in COVID wards. Infusion pumps are used in hospitals and other emergency centers to control and deliver doses of medication, and because they can be set to do this without constant supervision, they allow doctors and nurses to treat patients with minimal exposure to infection. Hence, the demand for infusion pumps grew significantly in 2020. This made the supply and distribution of infusion pumps a major challenge
Owing to increase in spending on long-term care, the preference for homecare settings has been rising substantially. Ambulatory infusion pumps in homecare settings are more in demand due to rise in expenditure majorly on hospitalization and increase in prevalence of chronic diseases. Increase in the rate of adopting ambulatory infusion pumps and rise in need to reduce hospital stays are critical factors for surge in demand for ambulatory infusion pumps in homecare settings
The global Intravenous infusion pump market is segmented into type, application, end user and region. By type, the market is categorized into volumetric infusion pumps, syringe infusion pumps & patient controlled analgesia infusion pumps. On the basis of application, it is divided into oncology, parenteral nutrition, analgesia/pain management, and others. Depending on end user, it is categorized into hospitals & clinics, home healthcare, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global Intravenous infusion pump market are F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun Holding GmbH & Co. KG, Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Medtronic, Smith Medical, ICU Medical, Inc., and Tandem Diabetes Care, Inc.
Infusion pump is a medical device that delivers fluids such as nutrients and medications into a patient’s body in controlled amounts. Infusion pumps are increasingly used in clinical settings such as hospitals, nursing homes, and in home.
In general, an infusion pump is operated by a trained user who programs the rate and duration of fluid delivery through a built-in software interface. Infusion pumps offer significant advantages over manual administration of fluids, including the ability to deliver fluids in small volumes and the ability to deliver fluids at precisely programmed rates or automated intervals. Furthermore, infusion pumps can deliver nutrients or medications, such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers.
Chronic diseases are the major cause of disability and deaths across the globe, and 80% of deaths due to chronic diseases occur in low- and middle-income countries. In addition, chronic diseases include cardiovascular diseases, stroke, cancer, chronic respiratory diseases, and diabetes, wherein cardiovascular disease is the major cause of deaths globally, according to WHO. The prevalence of cancer has increased drastically, raising the global burden to 19.3 million cases in 2020, as stated by the NCBI. Such diseases have become a major public health concern and need a quick and regulated mode of treatment. Rise in incidence of diseases such as cardiovascular and cancer has led to an increase in demand for intravenous infusion pump devices.
The possibility of medication errors exists due to increase in disease burden. Thus, there is a need for advanced delivery systems that are more safe, efficient, and standardized. Furthermore, the introduction of smart intravenous infusion pumps or next-generation intravenous pumps is imparting lucrative growth opportunities for the market. Smart pumps are intelligent intravenous infusion devices that are embedded with a computer software system aimed at decreasing drug dosing errors through the presence of drug libraries ensuring safe medication administration.
The applications of these intravenous pumps in intermittent therapy for delivery of antibiotics or continuous infusion therapy for the delivery of chemotherapeutic medications are prominent. According to NCBI, the use of ambulatory pumps is common and will continue to grow annually. Factors such as surge in geriatric population, rise in prevalence of chronic diseases, and low cost are likely to propel the market. Moreover, rise in the number of individuals undergoing surgeries globally for cosmetic, cancer, cardiovascular, or other ailments is likely to have a positive impact on the market growth.
Infusion pumps and ventilators can be considered critical devices, as these devices are used in ICUs, CCUs, and emergency departments. IV infusion is a common need in COVID wards. Infusion pumps are used in hospitals and other emergency centers to control and deliver doses of medication, and because they can be set to do this without constant supervision, they allow doctors and nurses to treat patients with minimal exposure to infection. Hence, the demand for infusion pumps grew significantly in 2020. This made the supply and distribution of infusion pumps a major challenge
Owing to increase in spending on long-term care, the preference for homecare settings has been rising substantially. Ambulatory infusion pumps in homecare settings are more in demand due to rise in expenditure majorly on hospitalization and increase in prevalence of chronic diseases. Increase in the rate of adopting ambulatory infusion pumps and rise in need to reduce hospital stays are critical factors for surge in demand for ambulatory infusion pumps in homecare settings
The global Intravenous infusion pump market is segmented into type, application, end user and region. By type, the market is categorized into volumetric infusion pumps, syringe infusion pumps & patient controlled analgesia infusion pumps. On the basis of application, it is divided into oncology, parenteral nutrition, analgesia/pain management, and others. Depending on end user, it is categorized into hospitals & clinics, home healthcare, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global Intravenous infusion pump market are F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, B. Braun Holding GmbH & Co. KG, Becton, Dickinson and Company, Baxter International, Inc., Terumo Corporation, Medtronic, Smith Medical, ICU Medical, Inc., and Tandem Diabetes Care, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current trends and future estimations and dynamics in the global intravenous infusion pump market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Type
- Volumetric Infusion Pumps
- Syringe Infusion Pumps
- Patient Controlled Analgesia Infusion Pumps
By Application
- Oncology
- Parenteral Nutrition
- Analgesia/Pain Management
- Others
By End User
- Hospitals & Clinics
- Home Healthcare
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- F. Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- B. Braun Holding GmbH & Co. KG
- Becton, Dickinson and Company
- Baxter International, Inc.
- Terumo Corporation
- Medtronic
- Smith Medical
- ICU Medical, Inc.
- Tandem Diabetes Care, Inc.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models]
CHAPTER 2: EXECUTIVE SUMMARY2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Top player positioning
3.4. Market dynamics
3.4.1. Drivers, restraints, and opportunity
3.4.2. Drivers
3.4.2.1. Increasing prevalence of chronic diseases and rising demand for ambulatory infusion pumps in home care settings
3.4.2.2. Technological advancements leading to products with improved features
3.4.2.3. Rising demand for ambulatory infusion pumps in homecare settings
3.4.3. Restraints
3.4.3.1. Product recalls
3.4.4. Opportunity
3.4.4.1. Emerging economies to offer growth opportunities
3.5. Impact of COVID-19 on intravenous infusion pump market
3.5.1. Overview
3.5.2. Impact analysis
CHAPTER 4: INTRAVENOUS INFUSION PUMP MARKET, BY TYPE4.1. Overview
4.1.1. Market size and forecast
4.2. Volumetric Infusion Pumps
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Syringe Infusion Pumps
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Patient Controlled Analgesia Infusion Pumps
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION5.1. Overview
5.1.1. Market size and forecast
5.2. Oncology
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Parenteral Nutrition
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Analgesia/Pain Management
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6: INTRAVENOUS INFUSION PUMP MARKET, BY END USER6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & Clinics
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Home Healthcare
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: INTRAVENOUS INFUSION PUMP MARKET, BY REGION7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key opportunities and forecast
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by type
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by end user
7.2.5.1. U.S.
7.2.5.1.1. U.S. market size and forecast, by type
7.2.5.1.2. U.S. market size and forecast, by application
7.2.5.1.3. U.S. market size and forecast, by end user
7.2.5.2. Canada
7.2.5.2.1. Canada market size and forecast, by type
7.2.5.2.2. Canada market size and forecast, by application
7.2.5.2.3. Canada market size and forecast, by end user
7.2.5.3. Mexico
7.2.5.3.1. Mexico market size and forecast, by type
7.2.5.3.2. Mexico market size and forecast, by application
7.2.5.3.3. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key opportunities and forecast
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by type
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by end user
7.3.5.1. Germany
7.3.5.1.1. Germany market size and forecast, by type
7.3.5.1.2. Germany market size and forecast, by application
7.3.5.1.3. Germany market size and forecast, by end user
7.3.5.2. France
7.3.5.2.1. France market size and forecast, by type
7.3.5.2.2. France market size and forecast, by application
7.3.5.2.3. France market size and forecast, by end user
7.3.5.3. UK
7.3.5.3.1. UK market size and forecast, by type
7.3.5.3.2. UK market size and forecast, by application
7.3.5.3.3. UK market size and forecast, by end user
7.3.5.4. Italy
7.3.5.4.1. Italy market size and forecast, by type
7.3.5.4.2. Italy market size and forecast, by application
7.3.5.4.3. Italy market size and forecast, by end user
7.3.5.5. Spain
7.3.5.5.1. Spain market size and forecast, by type
7.3.5.5.2. Spain market size and forecast, by application
7.3.5.5.3. Spain market size and forecast, by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe market size and forecast, by type
7.3.5.6.2. Rest of Europe market size and forecast, by application
7.3.5.6.3. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key opportunities and forecast
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by type
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by end user
7.4.5.1. Japan
7.4.5.1.1. Japan market size and forecast, by type
7.4.5.1.2. Japan market size and forecast, by application
7.4.5.1.3. Japan market size and forecast, by end user
7.4.5.2. China
7.4.5.2.1. China market size and forecast, by type
7.4.5.2.2. China market size and forecast, by application
7.4.5.2.3. China market size and forecast, by end user
7.4.5.3. Australia
7.4.5.3.1. Australia market size and forecast, by type
7.4.5.3.2. Australia market size and forecast, by application
7.4.5.3.3. Australia market size and forecast, by end user
7.4.5.4. India
7.4.5.4.1. India market size and forecast, by type
7.4.5.4.2. India market size and forecast, by application
7.4.5.4.3. India market size and forecast, by end user
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Rest of Asia-Pacific market size and forecast, by type
7.4.5.5.2. Rest of Asia- Pacific market size and forecast, by application
7.4.5.5.3. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key opportunities and forecast
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by type
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by end user
7.5.5.1. Brazil
7.5.5.1.1. Brazil market size and forecast, by type
7.5.5.1.2. Brazil market size and forecast, by application
7.5.5.1.3. Brazil market size and forecast, by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia market size and forecast, by type
7.5.5.2.2. Saudi Arabia market size and forecast, by application
7.5.5.2.3. Saudi Arabia market size and forecast, by end user
7.5.5.3. South Africa
7.5.5.3.1. South Africa market size and forecast, by type
7.5.5.3.2. South Africa market size and forecast, by application
7.5.5.3.3. South Africa market size and forecast, by end user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA market size and forecast, by type
7.5.5.4.2. Rest of LAMEA market size and forecast, by application
7.5.5.4.3. Rest of LAMEA market size and forecast, by end user
List of Tables
TABLE 01. INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY TYPE, 2020-2030 ($MILLION)
TABLE 02. INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR VOLUMETRIC INFUSION PUMPS, BY REGION, 2020-2030($MILLION)
TABLE 03. INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR SYRINGE INFUSION PUMPS, BY REGION, 2020-2030($MILLION)
TABLE 04. INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR PATIENT CONTROLLED ANALGESIA INFUSION PUMPS, BY REGION, 2020-2030($MILLION)
TABLE 05. INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 06. INTRAVENOUS INFUSION PUMP MARKET FOR ONCOLOGY REVENUE, BY REGION, 2020-2030($MILLION)
TABLE 07. PARENTERAL NUTRITION FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 08. ANALGESIA/PAIN MANAGEMENT FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 09. OTHERS FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 10. INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY END USER, 2020-2030($MILLION)
TABLE 11. INTRAVENOUS INFUSION PUMP MARKET FOR HOSPITALS & CLINICS REVENUE, BY REGION, 2020-2030($MILLION)
TABLE 12. INTRAVENOUS INFUSION PUMP MARKET FOR HOME HEALTHCARE REVENUE, BY REGION, 2020-2030($MILLION)
TABLE 13. INTRAVENOUS INFUSION PUMP MARKET FOR OTHERS REVENUE, BY REGION, 2020-2030($MILLION)
TABLE 14. INTRAVENOUS INFUSION PUMP MARKET, BY REGION, 2020-2030($MILLION)
TABLE 15. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 16. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 17. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 18. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 19. U.S. INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 20. U.S. INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 21. U.S. INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 22. CANADA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 23. CANADA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 24. CANADA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 25. MEXICO INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 26. MEXICO INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 27. MEXICO INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 28. EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 29. EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 30. EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 31. EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 32. GERMANY INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 33. GERMANY INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 34. GERMANY INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 35. FRANCE INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 36. FRANCE INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 37. FRANCE INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 38. UK INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 39. UK INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 40. UK INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 41. ITALY INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 42. ITALY INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 43. ITALY INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 44. SPAIN INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 45. SPAIN INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 46. SPAIN INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 47. REST OF EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 48. REST OF EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 49. REST OF EUROPE INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 50. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 51. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 52. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 53. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 54. JAPAN INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 55. JAPAN INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 56. JAPAN INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 57. CHINA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 58. CHINA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 59. CHINA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 60. AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 61. AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 62. AUSTRALIA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 63. INDIA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 64. INDIA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 65. INDIA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 66. REST OF ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 67. REST OF ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 68. REST OF ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 69. LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 70. LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 71. LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 72. LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 73. BRAZIL INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 74. BRAZIL INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 75. BRAZIL INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 76. SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 77. SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 78. SAUDI ARABIA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 79. SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 80. SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 81. SOUTH AFRICA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
TABLE 82. REST OF LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 83. REST OF LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 84. REST OF LAMEA INTRAVENOUS INFUSION PUMP MARKET, BY END USER, 2020-2030($MILLION)
List of Figures
FIGURE 01. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MODERATE BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. MODERATE THREAT OF SUBSTITUTION
FIGURE 07. MODERATE COMPETITIVE RIVALRY
FIGURE 08. TOP PLAYER POSITIONING, 2020
FIGURE 09. DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 10. INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2020-2030(%)
FIGURE 11. INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR SYRINGE INFUSION PUMPS, BY COUNTRY, 2020-2030(%)
FIGURE 12. INTRAVENOUS INFUSION PUMP MARKET REVENUE FOR PATIENT CONTROLLED ANALGESIA INFUSION PUMPS, BY COUNTRY, 2020-2030(%)
FIGURE 13. ONCOLOGY FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 14. PARENTERAL NUTRITION FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 15. ANALGESIA/PAIN MANAGEMENT FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 16. OTHERS FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 17. HOSPITALS & CLINICS FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 18. HOME HEALTHCARE FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 19. OTHERS FOR INTRAVENOUS INFUSION PUMP MARKET REVENUE, BY COUNTRY, 2020-2030(%)
Companies Mentioned
- F. Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- B. Braun Holding GmbH & Co. KG
- Becton
- Dickinson and Company
- Baxter International Inc.
- Terumo Corporation
- Medtronic
- Smith Medical
- ICU Medical Inc.
- Tandem Diabetes Care Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 178 |
| Published | August 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 4154.3 million |
| Forecasted Market Value ( USD | $ 8147.2 million |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
